THE LOWEST EFFECTIVE DOSE OF TISSUE PLASMINOGEN ACTIVATOR FOR FIBRINOLYSIS OF POSTVITRECTOMY FIBRIN

Abstract

Tissue plasminogen activator (tPA) has been shown to be effective at a dose of 25 μg in the treatment of severe postvitrectomy fibrin. However, a recent report based on an animal model indicates that retinal toxicity may occur at doses as low as 25 μg. This study uses a low dose (1.5 μg to 3 μg) of tPA for 34 injections in 26 eyes, and determines the lowest effective dose to be between 1.5 and 3 μg. Complete fibrinolysis was achieved in all 28 eyes in which 3 μg of tPA was administered within 10 days of vitrectomy, whereas partial fibrinolysis was achieved in eyes treated with 3 μg of tPA 27 days and 82 days after vitrectomy. Complete fibrinolysis occurred in only 1 of 4 eyes that receive 1.5 μg of tPA. A dose of 3 μg of tPA is recommended for treatment of severe fibrin after vitrectomy, as it has a wider margin of safety than do higher doses.